| | | | | |
| 3. | FAIR VALUE MEASUREMENTS |
Our financial instruments consist of cash, cash equivalents, investments, accounts receivable, accounts payable, and accrued liabilities. At August 2, 2025, and August 3, 2024, the carrying values of cash, accounts receivable, accounts payable, and accrued liabilities approximated fair value due to their short-term nature. We measure our cash equivalents and investments at fair value within Level 1 or Level 2 of the fair value hierarchy because we value these investments using unadjusted, quoted market prices; or alternative pricing sources and models utilizing market observable inputs, respectively.
Further, the Company measures the fair value of certain lease right of use assets and other long-lived assets subject to long-lived asset impairment using Level 3 unobservable inputs. Refer to 2. “Summary of Accounting Policies” for further details on impairment of long-lived assets.
Our cash equivalents and investments, which were accounted for as available-for-sale securities and were measured at fair value on a recurring basis as of August 2, 2025, and August 3, 2024, were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | August 2, 2025 | | August 3, 2024 |
| (in thousands) | | Level 1 | | Level 2 | | Level 3 | | Total | | Level 1 | | Level 2 | | Level 3 | | Total |
| Cash equivalents: | | | | | | | | | | | | | | | | |
| Money market funds | | $ | 59,945 | | | $ | — | | | $ | — | | | $ | 59,945 | | | $ | 84,594 | | | $ | — | | | $ | — | | | $ | 84,594 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| Investments: | | | | | | | | | | | | | | | | |
| U.S. Treasury securities | | 16,541 | | | — | | | — | | | 16,541 | | | 13,603 | | | — | | | — | | | 13,603 | |
Corporate bonds (1) | | — | | | 105,110 | | | — | | | 105,110 | | | — | | | 67,527 | | | — | | | 67,527 | |
| Asset backed securities | | — | | | 1,499 | | | — | | | 1,499 | | | — | | | — | | | — | | | — | |
| Yankee bonds | | — | | | 5,645 | | | — | | | 5,645 | | | — | | | — | | | — | | | — | |
| | | | | | | | | | | | | | | | |
| U.S. Agency securities | | — | | | — | | | — | | | — | | | — | | | 2,976 | | | — | | | 2,976 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| Total | | $ | 76,486 | | | $ | 112,254 | | | $ | — | | | $ | 188,740 | | | $ | 98,197 | | | $ | 70,503 | | | $ | — | | | $ | 168,700 | |
(1) For August 2, 2025, U.S. Treasury securities and corporate bonds includes both short-term investments with remaining maturities of less than one year, and long-term investments with remaining maturities over one year and less than five years.
There were no transfers of financial assets or liabilities into or out of Level 1, Level 2, or Level 3 during fiscal 2025 or fiscal 2024.
The following table sets forth the amortized cost, gross unrealized gains and losses, and fair values of our investments, which are accounted for as available-for-sale securities, as of August 2, 2025, and August 3, 2024:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | August 2, 2025 | | August 3, 2024 |
| (in thousands) | | Amortized Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | | Amortized Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value |
| Investments: | | | | | | | | | | | | | | | | |
| U.S. Treasury securities | | $ | 16,542 | | | $ | — | | | $ | (1) | | | $ | 16,541 | | | $ | 13,588 | | | $ | 16 | | | $ | (1) | | | $ | 13,603 | |
| Corporate bonds | | 105,115 | | | 28 | | | (33) | | | 105,110 | | | 67,451 | | | 88 | | | (12) | | | 67,527 | |
| Asset backed securities | | 1,499 | | | — | | | — | | | 1,499 | | | — | | | — | | | — | | | — | |
| Yankee bonds | | 5,644 | | | 1 | | | — | | | 5,645 | | | — | | | — | | | — | | | — | |
| | | | | | | | | | | | | | | | |
| U.S. Agency securities | | — | | | — | | | — | | | — | | | 2,973 | | | 3 | | | — | | | 2,976 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| Total | | $ | 128,800 | | | $ | 29 | | | $ | (34) | | | $ | 128,795 | | | $ | 84,012 | | | $ | 107 | | | $ | (13) | | | $ | 84,106 | |
No significant available-for-sale securities held as of the periods presented have been in a continuous unrealized loss position for more than 12 months as of August 2, 2025, and August 3, 2024.